Clinical Trial Update: Efficacy and Safety of a Sunscreen Against Porfimer Sodium-induced Phototoxicity to Visible Light [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating a sunscreen to prevent porfimer sodium–induced phototoxicity to visible light has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Barrett Esophagus with High-grade Dysplasia
• Esophageal Cancer
• Non-small Cell Lung Cancer

Drugs mentioned

• Sunscreen for porfimer sodium phototoxicity

Snippet

Sponsor: Pinnacle Biologics Inc. | Conditions: High-grade Dysplasia in Barrett Esophagus, Non Small Cell Lung Cancer | Phase 2 | Status: WITHDRAWN